Viveve Medical Performance
| VIVEDelisted Stock | USD 0.1 0.0005 0.53% |
The entity has a beta of 2.7, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Viveve Medical will likely underperform. Viveve Medical right now has a risk of 0.0%. Please validate Viveve Medical potential upside, rate of daily change, as well as the relationship between the Rate Of Daily Change and period momentum indicator , to decide if Viveve Medical will be following its existing price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Viveve Medical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Viveve Medical is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
| Begin Period Cash Flow | 6.5 M | |
| Total Cashflows From Investing Activities | -456 K |
Viveve |
Viveve Medical Relative Risk vs. Return Landscape
If you would invest 9.55 in Viveve Medical on September 21, 2024 and sell it today you would earn a total of 0.00 from holding Viveve Medical or generate 0.0% return on investment over 90 days. Viveve Medical is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than Viveve, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Viveve Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Viveve Medical's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Viveve Medical, and traders can use it to determine the average amount a Viveve Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| VIVE |
Based on monthly moving average Viveve Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Viveve Medical by adding Viveve Medical to a well-diversified portfolio.
Viveve Medical Fundamentals Growth
Viveve Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Viveve Medical, and Viveve Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Viveve Pink Sheet performance.
| Return On Equity | -2.11 | ||||
| Return On Asset | -0.62 | ||||
| Operating Margin | (3.10) % | ||||
| Current Valuation | 4.26 M | ||||
| Shares Outstanding | 10.72 M | ||||
| Price To Earning | (2.59) X | ||||
| Price To Book | 3.62 X | ||||
| Price To Sales | 0.66 X | ||||
| Revenue | 6.43 M | ||||
| EBITDA | (19.89 M) | ||||
| Cash And Equivalents | 9.43 M | ||||
| Cash Per Share | 0.88 X | ||||
| Total Debt | 5.12 M | ||||
| Debt To Equity | 1.12 % | ||||
| Book Value Per Share | 0.11 X | ||||
| Cash Flow From Operations | (12.88 M) | ||||
| Earnings Per Share | (2.55) X | ||||
| Total Asset | 25.91 M | ||||
| Retained Earnings | (68.62 M) | ||||
| Current Asset | 18.53 M | ||||
| Current Liabilities | 5.32 M | ||||
About Viveve Medical Performance
By analyzing Viveve Medical's fundamental ratios, stakeholders can gain valuable insights into Viveve Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Viveve Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Viveve Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Viveve Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. Viveve Medical, Inc. was founded in 2005 and is headquartered in Englewood, Colorado. Viveve Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 47 people.Things to note about Viveve Medical performance evaluation
Checking the ongoing alerts about Viveve Medical for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Viveve Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Viveve Medical is not yet fully synchronised with the market data | |
| Viveve Medical has some characteristics of a very speculative penny stock | |
| Viveve Medical has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 6.43 M. Net Loss for the year was (22.03 M) with profit before overhead, payroll, taxes, and interest of 620 K. | |
| Viveve Medical currently holds about 9.43 M in cash with (12.88 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.88, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing Viveve Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Viveve Medical's stock is overvalued or undervalued compared to its peers.
- Examining Viveve Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Viveve Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Viveve Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Viveve Medical's pink sheet. These opinions can provide insight into Viveve Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Consideration for investing in Viveve Pink Sheet
If you are still planning to invest in Viveve Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Viveve Medical's history and understand the potential risks before investing.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |